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Introduction     
The ACL fails to heal after rupture, due in part to a less effective injury 
response by the ACL cells, and in part to a lack of provisional clot 
formation intraarticularly. Therefore, the development of a biologically 
active scaffold that enhances ACL cell proliferation and matrix 
synthesis, and also serves as a substitute provisional scaffold for the 
ligament during the repair process is very desirable. We have previously 
shown that ACL cells can proliferate after ligament rupture, migrate into 
an adjacent provisional scaffold [1], and to take up a foreign transgene 
when delivered within a vector-laden hydrogel in vitro [2]. Based upon 
these data, in this study we further characterize the expression of foreign 
transgenes by ACL cells when cultured within collagen hydrogels and 
when transduced in situ while migrating out of ACL tissue pieces in 
explant culture. Moreover we report the healing response induced by the 
delivery of the IGF-1 transgene under these culture conditions.  
Methods  
Generation of adenoviral vectors:
 
Serotype 5, E1/E3 deleted adenoviral 
vectors of the first generation were generated by cre-lox recombination 
[1], containing complete cDNA conding sequences of the human IGF-1, 
the green fluorescent protein (GFP), and the firefly luciferase (Luc) 
gene. The resulting vectors were designated Ad.IGF-1, Ad.GFP and 
Ad.Luc. Monolayer and hydrogel culture and adenoviral transduction :
ACL cells were isolated by collagenase digestion from 6 bovine ACLs, 
seeded at 5*104 cell/mL in 12 well plates, and cultured in DMEM with 
10% FBS. After 24 hours cultures were transduced with Ad.GFP and 
Ad.IGF-1at 10, 100 and 300 multiplicities of infection (MOI), or were 
left uninfected. For the hydrogel cultures, aliquots 3*105 ACL cells were 
transduced with various m.o.i. of Ad.IGF-1, Ad.GFP and Ad.Luc, 
respectively, or were left uninfected. 24 hours after transduction, cells 
were resuspended in 200 µL of a bovine collagen hydrogel and 
maintained completed DMEM for up to 8 weeks. Migration study: ACL 
fascicles were prepared from bovine ACLs, divided into pieces of 
approximately 3 mm length and placed in explant culture at opposite 
ends of 5 mm diameter semicircular silicone tubes leaving an 
approximate 5 mm gap and fixed with needles. The gap between the 
fascicles was then subsequently filled with collagen hydrogel, containing 
108 infectious particles of Ad.IGF-1, Ad.GFP or no viral particles, 
respectively, and the constructs were placed into 12-well plates and 
cultured as stated above. Quantitation of transgene expressions: GFP 
expression was detected by fluorescence microscopy and flow 
cytometry, firelfly luciferase expression was quantified in a 
luminometer, and the IGF-1 transgene expression was determined in the 
supernatants by ELISA (R&D Systems). Cell proliferation and collagen 
production assays: DNA content was determined fluorometrically on 
proteinase K digested samples using Hoechst dye. Monolayer and gel 
cultures were also radiolabeled with  2µCi/mL 3H thymidine and 
14C proline at day 3, 7 and 14. Histology and immunohistochemistry:
Histologic analyses of the gels was performed on H&E stained 5 µm 
paraffin sections. For collagen synthesis, immunohistochemical staining 
for types I and III collagen were performed, using an FITC crosslinked 
antibodies for visualization.    
Results 
ACL cells in monolayer showed a dose-dependent expression of GFP 
and IGF-1 transgenes with 80 ng/mL maximum levels secreted IGF-1 at 
300 MOI. This resulted in increased cell proliferation and collagen 
production compared with the untransduced and GFP transduced 
controls (monolayer data not shown). In collagen hydrogels the 
transgenes for GFP, luciferase and IGF-1 were also expressed in a dose-
dependent fashion, after incorporation of transduced ACL cells in the 
collagen hydrogels, with maximum levels of 70 ng/mL secreted IGF-1 at 
day 3 at 300 MOI dose. This resulted in increased cellularitiy and 
collagen-production after 21 days in the IGF-1 compared with the GFP 
transduced gel cultures (Fig. 1A), as evidenced by DNA content (Fig. 
1B), histology and imunohistochemistry for type I and III collagen (not 
shown). A GFP timecourse study revealed the presence of GFP+ cells 
for up to 8 weeks in the hydrogels.  
Fig. 1:    
To determine if migrating ACL cells can be efficiently transduced by 
adenoviral vectors in situ we measured transgene expressions of  
migrating ACL cells from explant cultures into Ad.GFP and Ad.IGF-1 
laden collagen hydrogels. In this study the number of GFP+ cells 
increased progressively until day 21 (Fig. 2A), when the experiment was 
terminated. At day 21, there were very large numbers of GFP+ cells in 
the gel. These appear to represent the in situ transduction of ACL cells 
that have migrated from the cut end of the ligament. The Ad.IGF-1 
constructs showed peak levels of transgene expression at day 14 with 
100 ng/mL, with elevated expression levels over the total experimental 
period of 28 days. DNA (Fig. 2B) and histologic analysis revealed that 
the Ad.IGF-1 transduced constructs were more cellular than the Ad.GFP 
controls and immunohistochemical analyses demonstrated increased 
immunoreactivities for type I and III collagen.  
Fig.2: 
Conclusions 
The data from the markergene studies suggest that ACL cells can be 
efficiently transduced with adenoviral vectors and are able to express 
transgenes in a dose-dependent fashion in monolayer and incorporated 
within a collagen hydrogel. Moreover cells migrating out of ACL tissue 
pieces into vector-laden hydrogel continue to engage the recombinant 
adenovirus within the gel, and become transduced by it, for at least 21 
days. The IGF-1 transgene was able to stimulate a healing response in 
monolayer, hydrogel and explant cultures, with regard to increased 
cellularity and collagen production. These data confirm that it is possible 
to transduce ACL cells in situ as they migrate from a ruptured ACL and 
that they will respond in a suitable manner to the products of the 
transgenes they express. This permits optimism over a possible clinical 
use for this technology.  
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